JP2005524683A - 流体を除染するための方法および装置 - Google Patents
流体を除染するための方法および装置 Download PDFInfo
- Publication number
- JP2005524683A JP2005524683A JP2003583492A JP2003583492A JP2005524683A JP 2005524683 A JP2005524683 A JP 2005524683A JP 2003583492 A JP2003583492 A JP 2003583492A JP 2003583492 A JP2003583492 A JP 2003583492A JP 2005524683 A JP2005524683 A JP 2005524683A
- Authority
- JP
- Japan
- Prior art keywords
- fluid
- ozone
- chamber
- ultrasonic energy
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 655
- 238000000034 method Methods 0.000 title claims abstract description 323
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims abstract description 466
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 151
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 151
- 239000013060 biological fluid Substances 0.000 claims abstract description 39
- 239000007788 liquid Substances 0.000 claims description 139
- 238000005202 decontamination Methods 0.000 claims description 137
- 238000012545 processing Methods 0.000 claims description 128
- 230000003588 decontaminative effect Effects 0.000 claims description 123
- 238000002604 ultrasonography Methods 0.000 claims description 81
- 238000002156 mixing Methods 0.000 claims description 53
- 239000000758 substrate Substances 0.000 claims description 38
- 230000001678 irradiating effect Effects 0.000 claims description 26
- 239000010409 thin film Substances 0.000 claims description 20
- 230000005251 gamma ray Effects 0.000 claims description 15
- 238000005192 partition Methods 0.000 claims description 15
- 238000011282 treatment Methods 0.000 abstract description 69
- 230000005855 radiation Effects 0.000 abstract description 16
- 210000002381 plasma Anatomy 0.000 description 263
- 235000018102 proteins Nutrition 0.000 description 140
- 239000007789 gas Substances 0.000 description 103
- 239000001301 oxygen Substances 0.000 description 102
- 229910052760 oxygen Inorganic materials 0.000 description 102
- 230000008569 process Effects 0.000 description 95
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 91
- 230000006378 damage Effects 0.000 description 88
- 238000007872 degassing Methods 0.000 description 77
- 241000700605 Viruses Species 0.000 description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 64
- 239000000463 material Substances 0.000 description 62
- 238000013459 approach Methods 0.000 description 60
- 210000004369 blood Anatomy 0.000 description 53
- 239000008280 blood Substances 0.000 description 53
- 238000012360 testing method Methods 0.000 description 47
- 239000000047 product Substances 0.000 description 40
- 210000004027 cell Anatomy 0.000 description 39
- 230000008901 benefit Effects 0.000 description 35
- 230000000694 effects Effects 0.000 description 34
- 244000052769 pathogen Species 0.000 description 34
- 210000001772 blood platelet Anatomy 0.000 description 32
- 239000010836 blood and blood product Substances 0.000 description 29
- 238000010438 heat treatment Methods 0.000 description 29
- 210000003743 erythrocyte Anatomy 0.000 description 27
- 239000010410 layer Substances 0.000 description 27
- 229940125691 blood product Drugs 0.000 description 26
- 239000012678 infectious agent Substances 0.000 description 26
- 150000003254 radicals Chemical class 0.000 description 26
- 239000007921 spray Substances 0.000 description 26
- 239000000356 contaminant Substances 0.000 description 25
- 238000006243 chemical reaction Methods 0.000 description 22
- 230000009467 reduction Effects 0.000 description 22
- 238000000527 sonication Methods 0.000 description 22
- 239000000126 substance Substances 0.000 description 21
- 238000005516 engineering process Methods 0.000 description 20
- 230000002779 inactivation Effects 0.000 description 20
- 239000012528 membrane Substances 0.000 description 20
- 230000002572 peristaltic effect Effects 0.000 description 20
- 238000011109 contamination Methods 0.000 description 19
- 230000001717 pathogenic effect Effects 0.000 description 18
- 230000015572 biosynthetic process Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 102000004506 Blood Proteins Human genes 0.000 description 15
- 108010017384 Blood Proteins Proteins 0.000 description 15
- 230000005684 electric field Effects 0.000 description 15
- 230000000670 limiting effect Effects 0.000 description 15
- 239000004033 plastic Substances 0.000 description 15
- 229920003023 plastic Polymers 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 229920006362 Teflon® Polymers 0.000 description 14
- 239000000306 component Substances 0.000 description 14
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 13
- 239000003570 air Substances 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- 230000005484 gravity Effects 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 13
- 239000004809 Teflon Substances 0.000 description 12
- 238000009792 diffusion process Methods 0.000 description 12
- 230000033001 locomotion Effects 0.000 description 12
- -1 oxygen radical Chemical class 0.000 description 12
- 230000002829 reductive effect Effects 0.000 description 12
- 238000012546 transfer Methods 0.000 description 12
- 241000125945 Protoparvovirus Species 0.000 description 11
- 239000006260 foam Substances 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 229910052751 metal Inorganic materials 0.000 description 11
- 239000002184 metal Substances 0.000 description 11
- 230000036961 partial effect Effects 0.000 description 11
- 238000003860 storage Methods 0.000 description 11
- 241000283690 Bos taurus Species 0.000 description 10
- 102000008946 Fibrinogen Human genes 0.000 description 10
- 108010049003 Fibrinogen Proteins 0.000 description 10
- 241000725303 Human immunodeficiency virus Species 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000005859 coupling reaction Methods 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 229940012952 fibrinogen Drugs 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 238000009434 installation Methods 0.000 description 9
- 239000012460 protein solution Substances 0.000 description 9
- 238000010791 quenching Methods 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000006385 ozonation reaction Methods 0.000 description 8
- 244000045947 parasite Species 0.000 description 8
- 230000000171 quenching effect Effects 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 241000233866 Fungi Species 0.000 description 7
- 239000012503 blood component Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- 238000011161 development Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 108010054218 Factor VIII Proteins 0.000 description 6
- 102000001690 Factor VIII Human genes 0.000 description 6
- 238000002617 apheresis Methods 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 229960000074 biopharmaceutical Drugs 0.000 description 6
- 229910002092 carbon dioxide Inorganic materials 0.000 description 6
- 239000001569 carbon dioxide Substances 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000003599 detergent Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000282412 Homo Species 0.000 description 5
- 102000029797 Prion Human genes 0.000 description 5
- 108091000054 Prion Proteins 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 210000000170 cell membrane Anatomy 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000035602 clotting Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 5
- 230000006835 compression Effects 0.000 description 5
- 230000001066 destructive effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229960000301 factor viii Drugs 0.000 description 5
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 201000002364 leukopenia Diseases 0.000 description 5
- 231100001022 leukopenia Toxicity 0.000 description 5
- 239000010453 quartz Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 235000013601 eggs Nutrition 0.000 description 4
- 238000005868 electrolysis reaction Methods 0.000 description 4
- 239000005350 fused silica glass Substances 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000009257 reactivity Effects 0.000 description 4
- 238000005057 refrigeration Methods 0.000 description 4
- 230000033764 rhythmic process Effects 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- 238000009849 vacuum degassing Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 3
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 3
- 206010053567 Coagulopathies Diseases 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 239000003114 blood coagulation factor Substances 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000000498 cooling water Substances 0.000 description 3
- 230000000254 damaging effect Effects 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 238000011176 pooling Methods 0.000 description 3
- 238000005086 pumping Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000005393 sonoluminescence Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 239000012780 transparent material Substances 0.000 description 3
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 3
- 230000008016 vaporization Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 208000030507 AIDS Diseases 0.000 description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 238000004435 EPR spectroscopy Methods 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 2
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 2
- 208000009329 Graft vs Host Disease Diseases 0.000 description 2
- 208000031220 Hemophilia Diseases 0.000 description 2
- 208000009292 Hemophilia A Diseases 0.000 description 2
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- TVFDJXOCXUVLDH-RNFDNDRNSA-N cesium-137 Chemical compound [137Cs] TVFDJXOCXUVLDH-RNFDNDRNSA-N 0.000 description 2
- 230000002925 chemical effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000007687 exposure technique Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 229920002313 fluoropolymer Polymers 0.000 description 2
- 239000004811 fluoropolymer Substances 0.000 description 2
- 208000024908 graft versus host disease Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 229940072221 immunoglobulins Drugs 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 229910052756 noble gas Inorganic materials 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 238000013022 venting Methods 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 206010001935 American trypanosomiasis Diseases 0.000 description 1
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000606660 Bartonella Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 1
- 208000024699 Chagas disease Diseases 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
- 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
- 201000007336 Cryptococcosis Diseases 0.000 description 1
- 241000221204 Cryptococcus neoformans Species 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000007985 Erythema Infectiosum Diseases 0.000 description 1
- 108010014172 Factor V Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 241000702617 Human parvovirus B19 Species 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 241000282579 Pan Species 0.000 description 1
- 208000008071 Parvoviridae Infections Diseases 0.000 description 1
- 206010057343 Parvovirus infection Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 230000005679 Peltier effect Effects 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223821 Plasmodium malariae Species 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000004374 Tick Bites Diseases 0.000 description 1
- 241000223109 Trypanosoma cruzi Species 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 208000027276 Von Willebrand disease Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607447 Yersinia enterocolitica Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000003686 blood clotting factor concentrate Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 238000004517 catalytic hydrocracking Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000019987 cider Nutrition 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000006392 deoxygenation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000005686 electrostatic field Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003013 erythroid precursor cell Anatomy 0.000 description 1
- BFMKFCLXZSUVPI-UHFFFAOYSA-N ethyl but-3-enoate Chemical compound CCOC(=O)CC=C BFMKFCLXZSUVPI-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 150000003278 haem Chemical group 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000006911 nucleation Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229940118768 plasmodium malariae Drugs 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000011819 refractory material Substances 0.000 description 1
- 239000010832 regulated medical waste Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000008263 repair mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000013557 residual solvent Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000008864 scrapie Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000003894 surgical glue Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008646 thermal stress Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 229940033618 tisseel Drugs 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 239000010891 toxic waste Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 108010047303 von Willebrand Factor Proteins 0.000 description 1
- 208000012137 von Willebrand disease (hereditary or acquired) Diseases 0.000 description 1
- 102100036537 von Willebrand factor Human genes 0.000 description 1
- 229960001134 von willebrand factor Drugs 0.000 description 1
- 229940098232 yersinia enterocolitica Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
- A61L2/0094—Gaseous substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0035—Gamma radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0041—X-rays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
- A61L2/0058—Infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/025—Ultrasonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/20—Gaseous substances, e.g. vapours
- A61L2/202—Ozone
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Degasification And Air Bubble Elimination (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2002/008260 WO2003086479A1 (en) | 2002-04-12 | 2002-04-12 | Methods and apparatus for decontaminating fluids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2005524683A true JP2005524683A (ja) | 2005-08-18 |
Family
ID=29247951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003583492A Pending JP2005524683A (ja) | 2002-04-12 | 2002-04-12 | 流体を除染するための方法および装置 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1494723A4 (de) |
| JP (1) | JP2005524683A (de) |
| AU (1) | AU2002306757B2 (de) |
| CA (1) | CA2481144A1 (de) |
| MX (1) | MXPA04010027A (de) |
| WO (1) | WO2003086479A1 (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010503501A (ja) * | 2006-09-19 | 2010-02-04 | マコ ファルマ ソシエテ アノニム | 血液バッグシステム及び血液バッグシステムを用いた血小板濃縮物中の病原体を不活化するプロセス |
| JP2010530773A (ja) * | 2007-06-22 | 2010-09-16 | マコ ファルマ ソシエテ アノニム | 生体液における病原体及び／又は白血球の不活化のための照射装置及び不活化方法。 |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7358505B2 (en) * | 1998-09-15 | 2008-04-15 | Baxter International Inc. | Apparatus for fabricating a reconstitution assembly |
| US20070102858A1 (en) | 2005-11-07 | 2007-05-10 | Navigant Biotechnologies, Inc. | Clamps and methods for displacing fluid from portions of fluid containers |
| DE102005062410A1 (de) | 2005-12-23 | 2007-08-09 | Forschungsgemeinschaft Der Drk-Blutspendedienste E.V. | Verfahren zur Bestrahlung von Thrombozytenkonzentraten in flexiblen Behältnissen mit ultraviolettem Licht |
| DE102005062634A1 (de) | 2005-12-23 | 2007-06-28 | Blutspendedienst der Landesverbände des Deutschen Roten Kreuzes Niedersachsen, Sachsen-Anhalt, Thüringen, Oldenburg und Bremen gGmbH | Verfahren zur Inaktivierung von Pathogenen in Spenderblut, Blutplasma oder Erythrozytenkonzentraten in flexiblen Behältnissen unter Bewegung |
| DE102006027227A1 (de) | 2006-06-12 | 2008-01-03 | DRK - Blutspendedienst Baden-Württemberg-Hessen GmbH | Verfahren und Vorrichtung zum Inaktivieren von Viren und/oder Bakterien in flüssigen Medien, insbesondere in Blutplasmen und Serumkonserven |
| US7522702B2 (en) * | 2006-08-29 | 2009-04-21 | Harris Corporation | Soft x-ray radiation for biological pathogen decontamination and medical sterilization applications |
| US7776260B2 (en) * | 2006-12-11 | 2010-08-17 | Ethicon, Inc. | Apparatus and method for the irradiation of radiation sensitive materials |
| RU2419467C2 (ru) | 2006-12-20 | 2011-05-27 | Хару МИЯКЕ | Устройство для ультразвуковой терапии |
| ITMI20111439A1 (it) * | 2011-07-29 | 2013-01-30 | Paolo Benatti | Apparato per l'ozonizzazione di fluidi biologici, particolarmente per sangue. |
| US8940228B2 (en) | 2012-01-11 | 2015-01-27 | Terumo Bct, Inc. | Slidable clamp for port isolation |
| SE541036C2 (en) | 2014-09-15 | 2019-03-12 | Sangair Ab | Apparatus and system for ozonating blood, and method for ozonating blood prior to storage |
| KR102252218B1 (ko) * | 2019-11-01 | 2021-05-14 | 김진왕 | 친환경 스마트 혈액 모듈레이션 장치 |
| CN114225067B (zh) * | 2021-12-22 | 2024-01-26 | 中国医学科学院输血研究所 | 一种血液病原体灭活方法 |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6221A (ja) * | 1985-04-03 | 1987-01-06 | メディゾーン インターナショナル，インコーポレイティド | 血液製品中のウイルスの不活性化方法 |
| JPS63123377A (ja) * | 1986-09-16 | 1988-05-27 | アソシアシオン・レジオナル・ドウ・トランスフユジオン・サンギーヌ | 本質的にタンパク質性の生物学的材料中に存在する汚染性微生物をオゾン分解によつて不活化する方法、この方法で得られる生成物、並びにこれら生成物の生物学的及び分析的使用 |
| WO1994006380A1 (en) * | 1992-09-16 | 1994-03-31 | Hitachi, Ltd. | Ultrasonic irradiation apparatus and processor using the same |
| US5679257A (en) * | 1994-04-06 | 1997-10-21 | John T. Towles | Industrial waste water treatment |
| JPH11509210A (ja) * | 1995-07-14 | 1999-08-17 | クロア−ルージュ ド ベルジーク | 血液製剤中の汚染物質を不活性化する方法及び装置 |
| US5997812A (en) * | 1996-06-20 | 1999-12-07 | Coolant Treatment Systems, L.L.C. | Methods and apparatus for the application of combined fields to disinfect fluids |
| US6083387A (en) * | 1996-06-20 | 2000-07-04 | Burnham Technologies Ltd. | Apparatus for the disinfection of fluids |
| JP2000325702A (ja) * | 1999-05-17 | 2000-11-28 | Hideyuki Tabuchi | 脱気殺菌装置 |
| JP2001340452A (ja) * | 2000-05-31 | 2001-12-11 | Yoshiaki Nagaura | ウイルスを不活化する装置及び血液製剤の製造方法 |
| JP2002018202A (ja) * | 2000-07-07 | 2002-01-22 | National Institute Of Advanced Industrial & Technology | 超音波利用微小脱気装置 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4517159A (en) * | 1983-07-05 | 1985-05-14 | Karlson Eskil L | Sterilizer |
| JP3181071B2 (ja) * | 1991-06-28 | 2001-07-03 | 俊郎 立花 | 血液処理装置 |
| US5261874A (en) * | 1991-09-16 | 1993-11-16 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Extra-corporeal blood access, sensing, and radiation methods and apparatuses |
| JPH05104084A (ja) * | 1991-10-18 | 1993-04-27 | Nec Corp | 水中の有機塩素系溶剤成分を分解する方法およびその装置 |
| US5370740A (en) * | 1993-10-01 | 1994-12-06 | Hughes Aircraft Company | Chemical decomposition by sonication in liquid carbon dioxide |
| BE1010407A4 (fr) * | 1996-07-04 | 1998-07-07 | Undatim Ultrasonics | Procede et installation de traitement des eaux. |
| US6802892B2 (en) * | 1999-09-16 | 2004-10-12 | Vasogen Ireland Limited | Apparatus and process for conditioning organic fluid |
-
2002
- 2002-04-12 MX MXPA04010027A patent/MXPA04010027A/es not_active Application Discontinuation
- 2002-04-12 WO PCT/US2002/008260 patent/WO2003086479A1/en active Application Filing
- 2002-04-12 AU AU2002306757A patent/AU2002306757B2/en not_active Expired - Fee Related
- 2002-04-12 CA CA002481144A patent/CA2481144A1/en not_active Abandoned
- 2002-04-12 JP JP2003583492A patent/JP2005524683A/ja active Pending
- 2002-04-12 EP EP02807229A patent/EP1494723A4/de not_active Withdrawn
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6221A (ja) * | 1985-04-03 | 1987-01-06 | メディゾーン インターナショナル，インコーポレイティド | 血液製品中のウイルスの不活性化方法 |
| JPS63123377A (ja) * | 1986-09-16 | 1988-05-27 | アソシアシオン・レジオナル・ドウ・トランスフユジオン・サンギーヌ | 本質的にタンパク質性の生物学的材料中に存在する汚染性微生物をオゾン分解によつて不活化する方法、この方法で得られる生成物、並びにこれら生成物の生物学的及び分析的使用 |
| WO1994006380A1 (en) * | 1992-09-16 | 1994-03-31 | Hitachi, Ltd. | Ultrasonic irradiation apparatus and processor using the same |
| US5679257A (en) * | 1994-04-06 | 1997-10-21 | John T. Towles | Industrial waste water treatment |
| JPH11509210A (ja) * | 1995-07-14 | 1999-08-17 | クロア−ルージュ ド ベルジーク | 血液製剤中の汚染物質を不活性化する方法及び装置 |
| US5997812A (en) * | 1996-06-20 | 1999-12-07 | Coolant Treatment Systems, L.L.C. | Methods and apparatus for the application of combined fields to disinfect fluids |
| US6083387A (en) * | 1996-06-20 | 2000-07-04 | Burnham Technologies Ltd. | Apparatus for the disinfection of fluids |
| JP2000325702A (ja) * | 1999-05-17 | 2000-11-28 | Hideyuki Tabuchi | 脱気殺菌装置 |
| JP2001340452A (ja) * | 2000-05-31 | 2001-12-11 | Yoshiaki Nagaura | ウイルスを不活化する装置及び血液製剤の製造方法 |
| JP2002018202A (ja) * | 2000-07-07 | 2002-01-22 | National Institute Of Advanced Industrial & Technology | 超音波利用微小脱気装置 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010503501A (ja) * | 2006-09-19 | 2010-02-04 | マコ ファルマ ソシエテ アノニム | 血液バッグシステム及び血液バッグシステムを用いた血小板濃縮物中の病原体を不活化するプロセス |
| JP2010530773A (ja) * | 2007-06-22 | 2010-09-16 | マコ ファルマ ソシエテ アノニム | 生体液における病原体及び／又は白血球の不活化のための照射装置及び不活化方法。 |
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA04010027A (es) | 2005-07-01 |
| EP1494723A4 (de) | 2005-08-31 |
| EP1494723A1 (de) | 2005-01-12 |
| CA2481144A1 (en) | 2003-10-23 |
| WO2003086479A1 (en) | 2003-10-23 |
| AU2002306757B2 (en) | 2009-07-02 |
| AU2002306757A1 (en) | 2003-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7118852B2 (en) | Methods and apparatus for decontaminating fluids | |
| AU2002306757B2 (en) | Methods and apparatus for decontaminating fluids | |
| JP5474856B2 (ja) | 電磁放射により生物的サンプルを均等に処理する方法 | |
| US8525128B2 (en) | Method for the inactivation of pathogens in donor blood, blood plasma or erythrocyte concentrates in flexible containers under agitation | |
| US9320995B2 (en) | Method and apparatus for processing sample material | |
| CN1160453C (zh) | 从血浆中除去病毒因子的系统和方法 | |
| EP2077867B1 (de) | Blutbeutelsystem und verfahren zur inaktivierung von erregern in thrombozytenkonzentraten durch verwendung des blutbeutelsystems | |
| US6833108B2 (en) | Method and apparatus for inactivating contaminants in blood products | |
| US3837805A (en) | Apparatus for continuous sterilization at low temperature | |
| US3708263A (en) | Method for continuous sterilization at low temperature | |
| US20060127271A1 (en) | Non-thermal disinfection of biological fluids using non-thermal plasma | |
| JP2013544644A (ja) | 物質を音響的に処理するためのシステム | |
| JP2009500123A (ja) | 生物学的サンプル中の病原体を減少させるための方法 | |
| JP2009523710A (ja) | 柔軟な容器中で血小板濃縮物に紫外光を照射するための方法 | |
| JPH0788182A (ja) | 体外循環血液治療装置 | |
| US6495098B1 (en) | Method and apparatus for flowing sterile ultra-thin fluid membranes | |
| US20050189302A1 (en) | Viral inactivation using ozone | |
| TW200520799A (en) | Method for cleaning and sterilizing medical devices using dense phase fluid | |
| Purdum | Pathogen Inactivated Plasma Concentrated: Preparation and Uses | |
| JPH05132424A (ja) | 赤血球を含む血液製剤の紫外線照射方法 | |
| JPH11199490A (ja) | 活性酸素を用いた血液またはその成分の浄化方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081202 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090302 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090309 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090507 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090514 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090602 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100629 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101214 |